Announce Date | 08/08/2025 |
EPS Normalized Actual | $-1.7 (Miss by $-1.26) |
EPS GAAP Actual | $-1.7 (Miss by $-1.26) |
Revenue Actual | $1.0266B |
Revenue Surprise | Beat by $1026.6M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.24069 |
EPS GAAP Estimate | $0.24069 |
Revenue Estimate | $1.100265427B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 2.58 | 6.74 | 2.11086 | 2.97821 | 1 |
Dec 2028 | 2.99 | 5.82 | 2.55037 | 3.57029 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | -1.7 | -1.93143 | 1.0266B | -10.43% | -77.68M |
FQ1 2025 (Mar 2025) | -1.87 | -1.87 | 0.9939B | -1.2% | 993.9M |
FQ4 2024 (Dec 2024) | -0.47 | -0.47 | 0.9495B | -2.84% | 949.5M |
FQ3 2024 (Sep 2024) | -1.24 | -1.24 | 4.1931B | 51.42% | 4193.1M |
FQ2 2024 (Jun 2024) | -0.48 | -0.48 | 1.1337B | 10.22% | 1133.7M |
FQ1 2024 (Mar 2024) | -0.51 | -0.51 | 1.0058B | 96.17% | 1005.8M |
FQ4 2023 (Dec 2023) | -0.59 | -0.59 | 0.9765B | -2.39% | 976.5M |
FQ3 2023 (Sep 2023) | 1.26 | 1.26 | 2.0372B | 42.81% | 2037.2M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.24069
Consensus Revenue Estimates
1.100265427B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | -0.066405 | -- | -0.07781448 | -0.05232404 | 1 |
FQ3 2027 (Sep 2027) | -0.24532 | -- | -0.29074 | -0.18078 | 1 |
FQ2 2027 (Jun 2027) | -0.25402 | -- | -0.30105 | -0.18719 | 1 |
FQ1 2027 (Mar 2027) | -0.26279 | -- | -0.31144 | -0.19366 | 1 |
FQ4 2026 (Oct 2026) | 0.004385 | -- | 0.00394228 | 0.0049323 | 0 |
FQ3 2026 (Jul 2026) | -0.00303 | -- | -0.00340818 | -0.00272409 | 0 |
FQ2 2026 (Jun 2026) | -0.00303 | -56005.61 | -0.00341716 | -0.00275855 | 1 |
FQ1 2026 (Mar 2026) | -0.010483 | -17738.41 | -0.01182247 | -0.00954386 | 1 |
FQ4 2025 (Oct 2025) | 0.24982 | 288.14 | 0.2246 | 0.281 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.32B | -- | 1.11B | 1.5B | 2 |
FQ3 2027 (Sep 2027) | 1.16B | -- | 0.93B | 1.33B | 2 |
FQ2 2027 (Jun 2027) | 1.15B | -- | 0.92B | 1.32B | 2 |
FQ1 2027 (Mar 2027) | 1.14B | -- | 0.91B | 1.31B | 2 |
FQ4 2026 (Oct 2026) | 1.18B | -- | 1.09B | 1.3B | 1 |
FQ3 2026 (Jul 2026) | 1.18B | -- | 1.09B | 1.29B | 1 |
FQ2 2026 (Jun 2026) | 1.18B | 12.75 | 1.1B | 1.29B | 1 |
FQ1 2026 (Mar 2026) | 1.17B | 14.95 | 1.09B | 1.28B | 1 |
FQ4 2025 (Oct 2025) | 1.11B | 14.56 | 1.03B | 1.22B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.23143 | -1.7 | -1.93143 | 113.61% |
FQ1 2025 (Mar 2025) | -1.87 | -1.87 | 100% | |
FQ4 2024 (Dec 2024) | -0.47 | -0.47 | 100% | |
FQ3 2024 (Sep 2024) | -1.24 | -1.24 | 100% | |
FQ2 2024 (Jun 2024) | -0.48 | -0.48 | 100% | |
FQ1 2024 (Mar 2024) | -0.51 | -0.51 | 100% | |
FQ4 2023 (Dec 2023) | -0.59 | -0.59 | 100% | |
FQ3 2023 (Sep 2023) | 1.26 | 1.26 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $1.1B | $1.03B | $-77.68M | -7.57% |
FQ1 2025 (Mar 2025) | $0B | $0.99B | $993.9M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0.95B | $949.5M | 100% |
FQ3 2024 (Sep 2024) | $0B | $4.19B | $4193.1M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.13B | $1133.7M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.01B | $1005.8M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.98B | $976.5M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.04B | $2037.2M | 100% |